Company: VCYT
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001384101-25-000051
Chunk: 15

Company: VERACYTE, INC.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 15
---
 has determined that, except for Mr. Stapley, each individual who currently serves as a member of our Board of Directors is, and each individual who served as a member of our Board of Directors in 2024 was, an “independent director” within the meaning of applicable rules of The Nasdaq Stock Market (“Nasdaq”). The Nasdaq independence definition includes a series of objective tests, including that the director is not, and has not been for at least three years, one of our employees and that neither the director nor any of his family members has engaged in various types of business dealings with us. As a result, Mr. Stapley is not considered independent as he serves as our Chief Executive Officer. In addition, as required by Nasdaq rules, for each of Ms. Bhanji, Ms. Eastham, Dr. Epstein, Dr. Barr, Mr. Holstein, Mr. Jones, Dr. Miller and Mr. Shafer, the Board of Directors considered their relationships and transactions with us and our security holders and has made a subjective determination that no relationships exist, which, in the opinion of our Board of Directors, would interfere with the exercise of their independent judgment in carrying out the responsibilities of a director. In making these determinations, our Board of Directors reviewed and discussed information provided by the directors with regard to each director’s business and personal activities and relationships as they may relate to us and our management. There are no family relationships among any of our directors or executive officers.

#### Veracyte2025 Proxy Statement15

#### Proposal One
Compensation Committee Interlocks and Insider Participation

The members of our Compensation Committee during 2024 included John L. Bishop, until his term ended on June 12, 2024, Karin Eastham, Jens Holstein and Brent Shafer. No member of our Compensation Committee in 2024 was at any time during 2024 or at any other time an officer or employee of ours, and none had or have any relationships with us that are required to be disclosed under Item 404 of Regulation S-K. None of our executive officers has served as a member of the Board of Directors, or as a member of the compensation or similar committee, of any entity that has one or more executive officers who served on our Board of Directors or Compensation Committee during 2024.

Board Meetings

The Board of Directors held seven meetings and acted by written consent four times during 2024. Each director attended at least 80% of the aggregate number of meetings held by